Bradyzide di(trifluoroacetate) salt hydrate
SIGMA/B1680 - ≥98%
Synonym: (S)
Empirical Formula (Hill Notation): C32H42N8O5S2 · 2C2HF3O2 · xH2O
Molecular Weight: 910.90 (anhydrous basis)
MDL Number: MFCD02684401
Linear Formula: C32H42N8O5S2 · 2C2HF3O2 · xH2O
Product Type: Chemical
| assay | ≥98% |
| form | solid |
| Quality Level | 100 ![]() |
| solubility | H2O: >40 mg/mL |
| storage temp. | −20°C |
| Biochem/physiol Actions: | Potent, orally active, non-peptide B2 bradykinin receptor antagonist. |
| Features and Benefits: | This compound was developed by Novartis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 25 mg in poly bottle |
| Packaging: | 5 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% |
| Storage Temp. | −20°C |
| UNSPSC | 41106200 |

